Aroa Biosurgery Limited (ARX)
ASX 
Summary
Aroa Biosurgery Limited (AROAF) Discusses Findings and Commercial Impact of Symphony Randomized Controlled Trial Transcript
Aroa Biosurgery Limited (AROAF) Discusses Findings and Commercial Impact of Symphony Randomized Controlled Trial Transcript
Aroa Biosurgery Limited (AROAF) Discusses Interim Analysis Findings From Ongoing MASTRR Registry Study Transcript
Aroa Biosurgery Limited (AROAF) Discusses Interim Analysis Findings From Ongoing MASTRR Registry Study Transcript
Inside Biotech: Aroa Biosurgery's Symphony improves diabetic foot ulcer healing in US clinical trial
Aroa Biosurgery Ltd (ASX:ARX, OTC:AROAF) has reported positive results from a US randomised controlled trial showing its Symphony wound care product significantly improved healing outcomes for diabetic foot ulcers when added to standard care. The prospective multicentre study enrolled 143 patients across 10 US sites and found 55% of diabetic foot ulcers treated with Symphony plus standard care achieved complete wound closure within 12 weeks, compared with 35% for patients receiving standard care alone.
Aroa Biosurgery Limited (ARX) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Aroa Biosurgery Limited ever had a stock split?
Aroa Biosurgery Limited Profile
| Banks Industry | Financials Sector | Mr. Robin Antony Vince CEO | ASX Exchange | Q05263100 CUSIP |
| United States Country | 52,600 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
The Bank of New York Mellon Corporation, founded in 1784 and based in New York, New York, operates globally, providing a comprehensive suite of financial products and services. Through its various segments including Securities Services, Market and Wealth Services, Investment and Wealth Management, among others, the company caters to a diverse client base. This includes central banks, sovereign wealth funds, financial institutions, asset managers, insurance companies, corporations, local authorities, high-net-worth individuals, and family offices. The Bank of New York Mellon Corporation is dedicated to meeting the evolving needs of its clients, leveraging its extensive history and forward-thinking approach to finance.
Products and Services
Securities Services: Includes custody, trust and depositary, and accounting services. Offers exchange-traded funds, middle-office solutions, transfer agency services, and administration for private equity and real estate funds. Additionally, it provides foreign exchange, securities lending, liquidity/lending services, and data analytics. Trustee, paying agency, fiduciary, escrow, and other financial and support services for brokers and investors are also available.
Market and Wealth Services: Offers clearing and custody services, alongside investment, wealth, and retirement solutions. Provides technology and enterprise data management, trading, and prime brokerage services. Also includes integrated cash management solutions like payments, foreign exchange, liquidity management, receivables processing, payables management, and trade finance and processing services.
Investment and Wealth Management: Delivers investment management strategies and products, investment management, custody, wealth and estate planning, private banking, and information management services. This segment is focused on distributing investment products and providing investment advice to a wide range of clients.
Other Services: Engages in leasing, corporate treasury activities, derivative and other trading operations, management of corporate and bank-owned life insurance, investments in renewable energy, and business exit planning services. This segment reflects the company's broader financial capabilities and its commitment to offering comprehensive financial solutions.
Contact Information
